
Woolsey
December 1, 2026
Woolsey is developing an oral treatment to protect motor neurons and preserve physical function in people living with ALS.

Woolsey is developing an oral treatment to protect motor neurons and preserve physical function in people living with ALS.

Brook is giving health systems the technology, clinical teams, and infrastructure to support patients beyond the traditional office visit

Brook is giving health systems the technology, clinical teams, and infrastructure to support patients beyond the traditional office visit

A new therapeutic modality designed to directly target and destroy disease gene sequences rather than simply treat the symptoms of a disease.

Kesmalea is developing an oral, brain-penetrant drug designed to selectively eliminate a protein strongly associated with Alzheimer’s progression

More than 11 million Americans over the age of 50 are affected by debilitating midfoot osteoarthritis, now there’s a solution

abioSCOPE® is point-of-care platform that measures a biomarker that may begin rising 48 to 72 hours before a clinical diagnosis for sepsis

A new therapeutic modality designed to directly target and destroy disease gene sequences rather than simply treat the symptoms of a disease

HDT Bio is developing a new immune-maintenance therapy for breast cancer patients designed to prevent relapse years after successful treatment.

Brook is giving health systems the technology, clinical teams, and infrastructure to support patients beyond the traditional office visit

PortIO is developing the first implantable intraosseous port for long-term vascular access.

Axena Health is a commercial-stage women’s health company focused on transforming the treatment of urinary incontinence.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |